(3-fluoro-8-(1-methyl-1H-pyrazol-4-yl)-5,11-dihydro-6H-benzo[b]pyrido[2,3-e][1,4]diazepin-6-yl)((2R,5S)-5-isopropoxytetrahydro-2H-pyran-2-yl)methanone

ID: ALA5093219

Chembl Id: CHEMBL5093219

PubChem CID: 166632155

Max Phase: Preclinical

Molecular Formula: C25H28FN5O3

Molecular Weight: 465.53

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CC(C)O[C@H]1CC[C@H](C(=O)N2Cc3cc(F)cnc3Nc3ccc(-c4cnn(C)c4)cc32)OC1

Standard InChI:  InChI=1S/C25H28FN5O3/c1-15(2)34-20-5-7-23(33-14-20)25(32)31-13-17-8-19(26)11-27-24(17)29-21-6-4-16(9-22(21)31)18-10-28-30(3)12-18/h4,6,8-12,15,20,23H,5,7,13-14H2,1-3H3,(H,27,29)/t20-,23+/m0/s1

Standard InChI Key:  YLJQVHPDRBPSDB-NZQKXSOJSA-N

Alternative Forms

1. Parent:

   

   ALA5093219

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 465.53

Molecular Weight (Monoisotopic): 465.2176

AlogP: 4.18

#Rotatable Bonds: 4

Polar Surface Area: 81.51

Molecular Species: NEUTRAL

HBA: 7

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 8

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 12.13

CX Basic pKa: 2.43

CX LogP: 3.09

CX LogD: 3.09

Aromatic Rings: 3

Heavy Atoms: 34

QED Weighted: 0.62

Np Likeness Score: -0.73

References

1. Huang C, Fischer C, Machacek MR, Bogen S, Biftu T, Huang X, Reutershan MH, Otte R, Hong Q, Wu Z, Yu Y, Park M, Chen L, Biju P, Knemeyer I, Lu P, Kochansky CJ, Hicks MB, Liu Y, Helmy R, Fradera X, Donofrio A, Close J, Maddess ML, White C, Sloman DL, Sciammetta N, Lu J, Gibeau C, Simov V, Zhang H, Fuller P, Witter D..  (2022)  Diminishing GSH-Adduct Formation of Tricyclic Diazepine-based Mutant IDH1 Inhibitors.,  13  (4.0): [PMID:35450359] [10.1021/acsmedchemlett.2c00089]

Source

Source(1):

• Scientific Literature